even though its a new presentation, its already out of date.  It doesn't reflect the XOMA royalty sale announced on November 3rd (slide 6)

It appears to me as though they may be seeking a partner to licence out this new drug (XB3 + Progranulin) to.  It looks as though they are pushing this new proof of concept drug.  If it works, it would be very lucrative.